Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Neovacs SA News

    0,30 € 0,00% +0,00 €
    15:43:00 Uhr Gettex aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A400CN
    ISIN: FR001400MV37
    Typ: Aktie

    Neovacs SA News

    06.12.19 - GlobeNewswire
    OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS
    13.11.19 - GlobeNewswire
    NEOVACS REQUESTS A REORGANIZATION PROCEEDINGS OF THE COMPANY
    02.10.19 - GlobeNewswire
    NEOVACS ANNOUNCES ITS 2019 HALF-YEAR RESULTS
    30.09.19 - GlobeNewswire
    NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER
    PRESS RELEASE · PRESS RELEASE   · PRESS RELEASE
    09.09.19 - GlobeNewswire
    Neovacs : 2019 Financial Calendar
    09.07.19 - GlobeNewswire
    NEOVACS ANNOUNCES THAT THE POSITIVE RESULTS OF ITS PROOF OF CONCEPT IN ALLERGIES WITH IL-4 / IL-13 KINOID HAVE TRIGGERED THE FIRST PAYMENT OF THE ANR GRANT
    27.06.19 - GlobeNewswire
    NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENTIFIC ADVISOR
    05.06.19 - GlobeNewswire
    Neovacs to present the pre-clinical results of its IFNalpha Kinoid to treat type 1 diabetes - American Diabetes Association's 79th scientific sessions
    16.05.19 - GlobeNewswire
    Neovacs to present the pre-clinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid to treat allergic Asthma
    09.04.19 - GlobeNewswire
    Neovacs announces the full results of its Phase IIb Clinical study of IFNalpha Kinoid in lupus - 13th International Lupus Congress 2019
    05.04.19 - GlobeNewswire
    2019 Financial Calendar
    01.04.19 - GlobeNewswire
    Neovacs announces an agreement with Biosyn GmbH to diversify its supply of Keyhole Limpet Hemocyanin (KLH)
    PRESS RELEASE · PRESS RELEASE · PRESS RELEASE
    27.03.19 - GlobeNewswire
    NEOVACS STRENGTHENS ITS FINANCIAL STRUCTURE: ISSUANCE OF "ORNANE" FOR A MAXIMUM AMOUNT OF €10M, WITHOUT STOCK SUBSCRIPTION WARRANTS
    25.03.19 - GlobeNewswire
    Neovacs reports full-year 2018 Financial results and provides corporate update
    RESS RELEASE · PRESS RELEASE   · PRESS RELEASE
    21.03.19 - GlobeNewswire
    Neovacs to present the preclinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid at Keystone Congress
    20.02.19 - GlobeNewswire
    Neovacs announces two appointments to its executive committee
    05.02.19 - GlobeNewswire
    Neovacs to host KOL Meeting to discuss its therapeutic vaccin IFNalpha Kinoid for lupus treatment - February 11th Paris
    31.01.19 - GlobeNewswire
    Neovacs announces its clinical advisory board meeting to design the Phase III Study for IFNalpha Kinoide in lupus - Paris February 11th
    24.01.19 - GlobeNewswire
    Neovacs to present full results from the Phase IIb IFNalpha Kinoid clinical study at the 13th International Lupus Congress
    PRESS RELEASE · PRESS RELEASE · PRESS RELEASE
    08.01.19 - GlobeNewswire
    NEOVACS SECURES FINANCING FROM THE ANR - THE FRENCH NATIONAL RESEARCH AGENCY - TO DEVELOP THE IL-4/IL-13 KINOID AS AN ALLERGY TREATMENT
    PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS SECURES FINANCING FROM THE ANR - THE FRENCH NATIONAL RESEARCH AGENCY - TO DEVELOP THE ...

    Newssuche

    Videos

    newspaper
    26.04.24 -5,94%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »